Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.05	3.3	0.81	49.95	11.2	5.67
Short-Term Investments	18.5	20.2	26.51	0.3	72.93	30.03
Cash & Short-Term Investments	20.55	23.5	27.32	50.24	84.13	35.71
Cash Growth	-12.31%	-14.00%	-45.63%	-40.28%	135.61%	197.36%
Other Receivables	1.34	1.42	0.23	0.65	1.2	-
Receivables	1.34	1.42	0.23	0.65	1.2	-
Prepaid Expenses	0.75	0.88	1.11	1.44	1.11	1.24
Restricted Cash	-	-	-	-	-	1.17
Other Current Assets	0.01	0.2	5.11	-	-	-
Total Current Assets	22.65	25.99	33.76	52.33	86.44	38.12
Property, Plant & Equipment	1.07	1.15	2.58	14.9	8.22	2.14
Other Long-Term Assets	0.32	0.54	0.49	0.41	0.49	0.1
Total Assets	24.04	27.69	36.83	67.64	95.15	40.36
Accounts Payable	0.53	0.81	0.83	1.95	0.88	0.46
Accrued Expenses	2.37	2.61	3.66	4.01	3.22	2.54
Current Portion of Leases	0.24	0.24	0.35	0.65	0.62	0.2
Other Current Liabilities	-	0.14	1.23	-	-	1.17
Total Current Liabilities	3.14	3.8	6.06	6.61	4.72	4.37
Long-Term Leases	0.26	0.3	0.69	4.19	5.39	0.5
Total Liabilities	3.41	4.1	6.75	10.8	10.11	4.87
Common Stock	2.71	2.69	2.14	2.12	2.11	1.65
Additional Paid-In Capital	147.38	146.91	138.94	136.65	133.8	70.36
Retained Earnings	-130.56	-127.11	-112.09	-83.03	-51.97	-37.5
Comprehensive Income & Other	1.1	1.1	1.1	1.1	1.1	0.98
Total Common Equity	20.63	23.59	30.08	56.84	85.04	35.49
Shareholders' Equity	20.63	23.59	30.08	56.84	85.04	35.49
Total Liabilities & Equity	24.04	27.69	36.83	67.64	95.15	40.36
Total Debt	0.5	0.53	1.03	4.85	6.01	0.7
Net Cash (Debt)	20.05	22.96	26.29	45.4	78.12	35.01
Net Cash Growth	-10.93%	-12.65%	-42.09%	-41.89%	123.18%	202.11%
Net Cash Per Share	0.92	1.12	1.42	2.47	4.37	2.66
Filing Date Shares Outstanding	23.85	23.65	18.6	18.42	18.37	18.31
Total Common Shares Outstanding	23.85	23.65	18.6	18.42	18.33	14.59
Working Capital	19.5	22.19	27.7	45.72	81.72	33.75
Book Value Per Share	0.86	1.00	1.62	3.09	4.64	2.43
Tangible Book Value	20.63	23.59	30.08	56.84	85.04	35.49
Tangible Book Value Per Share	0.86	1.00	1.62	3.09	4.64	2.43
Machinery	2.7	2.68	2.98	3.38	2.34	1.53
Leasehold Improvements	0.95	0.95	1.43	8.61	1.52	0.71

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q